Dex-Cell Hysteroscopy Fluid Delivery Device
by Dexide, Inc. 510(k)
Active
510(k) K892001
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK892001 | Date16 Jun 1989 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 6 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- HIG
- Device Class
- Class II
- Regulation
- 21 CFR Part 884.1700
- Advisory Committee
- Obstetrics/Gynecology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 6 Oct 2026
This is an insufflator, hysteroscopic device used for fluid delivery during hysteroscopy procedures. It is classified as a Class II medical device under FDA regulation number 884.1700.
The device received FDA 510(k) clearance (K892001) on June 16, 1989, and is manufactured by Dexide, Inc. It is supplied as a reusable or single-use system depending on configuration, intended for use in obstetrics and gynecology clinical settings.
Other devices from Dexide, Inc.
Questions
AI-generated answers, 6 Oct 2026
What is the DEX-CELL hysteroscopy fluid delivery device used for?
The DEX-CELL hysteroscopy fluid delivery device is an insufflator used for fluid delivery during hysteroscopy procedures, as it is classified under FDA regulation number 884.1700 for hysteroscopic insufflators intended to distend the uterine cavity with fluid for visualization.
How is the DEX-CELL hysteroscopy fluid delivery device supplied?
The DEX-CELL hysteroscopy fluid delivery device is supplied as a reusable or single-use system depending on configuration, allowing flexibility for clinical settings based on infection control protocols and facility preferences for reprocessing or disposal.
What regulatory pathway was used for the DEX-CELL hysteroscopy fluid delivery device?
The DEX-CELL hysteroscopy fluid delivery device received FDA 510(k) clearance (K892001) on June 16, 1989, through a traditional submission demonstrating substantial equivalence to a legally marketed predicate device under Class II regulations for hysteroscopic insufflators.